Cargando…

Impact of Extraskeletal Metastases on Skeletal-Related Events in Metastatic Castration-Resistant Prostate Cancer with Bone Metastases

The therapeutic landscape of metastatic castration-resistant prostate cancer (mCRPC) has substantially evolved over the last decade. Nonetheless, a better understanding of bone-targeted agents (BTAs) action in mCRPC remains an unmet need. Theuse of BTAs aims to reduce the incidence of skeletal-relat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lobo-Martins, Soraia, Ferreira, Arlindo R., Mansinho, André, Casimiro, Sandra, Leitzel, Kim, Ali, Suhail, Lipton, Allan, Costa, Luís
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7463577/ https://www.ncbi.nlm.nih.gov/pubmed/32722128 http://dx.doi.org/10.3390/cancers12082034

Ejemplares similares

Pancreatic Extraskeletal Osteosarcoma Metastasizing to the Scalp
por: Kim, Young Jae, et al.
Publicado: (2018)

Targeting Bone Metastases in Metastatic Castration-Resistant Prostate Cancer
por: El-Amm, Joelle, et al.
Publicado: (2016)

Extraskeletal myxoid chondrosarcoma with massive pulmonary metastases
por: Paoluzzi, Luca, et al.
Publicado: (2018)

Case Series: “Silent” Spinal Epidural Metastases in Metastatic Castrate-Resistant Prostate Cancer
por: Sabanathan, Dhanusha, et al.
Publicado: (2023)

Lymphangitic Pulmonary Metastases in Castrate-Resistant Prostate Adenocarcinoma
por: Meyer, Andrew, et al.
Publicado: (2012)

Denosumab for the prevention of skeletal complications in metastatic castration-resistant prostate cancer: comparison of skeletal-related events and symptomatic skeletal events
por: Smith, M. R., et al.
Publicado: (2015)

Denosumab for the prevention of skeletal complications in metastatic castration-resistant prostate cancer: comparison of skeletal-related events and symptomatic skeletal events
Publicado: (2015)

Current perspectives on bone metastases in castrate-resistant prostate cancer
por: Logothetis, Christopher, et al.
Publicado: (2018)

Leptomeningeal Metastases in a Patient with Castration-Resistant Prostate Cancer
por: Koie, Takuya, et al.
Publicado: (2020)

Immunosuppressive tumor microenvironment in extraskeletal myxoid chondrosarcoma: A case of pleural metastases
por: Ogata, Ryosuke, et al.
Publicado: (2022)

Levels of Circulating Fibroblast Growth Factor 23 (FGF23) and Prognosis in Cancer Patients with Bone Metastases
por: Mansinho, André, et al.
Publicado: (2019)

The prognostic role of RANK SNP rs34945627 in breast cancer patients with bone metastases
por: Ferreira, Arlindo, et al.
Publicado: (2016)

Radium-223 for the Management of Bone Metastases in Castration-Resistant Prostate Cancer
por: Cox, Heather, et al.
Publicado: (2015)

PSMA-PET Detection of Unusual Metastases in Castrate-Sensitive Prostate Carcinoma
por: Harris, Nathanial, et al.
Publicado: (2023)

Extraskeletal Mesenchymal Chondrosarcoma, a Rare Entity with Unusual Metastases: A Case Report
por: Ali, Afaque, et al.
Publicado: (2021)

Pretreatment visceral metastases in castration resistant metastatic prostate cancer: role in prediction versus actual site of disease progression
por: Ruchalski, Kathleen, et al.
Publicado: (2022)

Pain in castration-resistant prostate cancer with bone metastases: a qualitative study
por: Gater, Adam, et al.
Publicado: (2011)

Androgen Receptor Variants Occur Frequently in Castration Resistant Prostate Cancer Metastases
por: Zhang, Xiaotun, et al.
Publicado: (2011)

Treatment of castration-resistant prostate cancer and bone metastases with radium-223 dichloride
por: Lien, Lise Marie E, et al.
Publicado: (2015)

The Economic Burden of Metastatic Castration Resistant Prostate Cancer and Skeletal Related Events in Japanese University Hospitals
por: Satoh, Takefumi, et al.
Publicado: (2018)

Clinical and radiologic features of extraskeletal myxoid chondrosarcoma including initial presentation, local recurrence, and metastases
por: Kapoor, Neena, et al.
Publicado: (2014)

Assessment of the viability and treatment response of bone metastases in patients with metastatic castration-resistant prostate cancer using choline PET/CT
por: Kitajima, Kazuhiro, et al.
Publicado: (2021)

Assessment of Skeletal Tumor Load in Metastasized Castration-Resistant Prostate Cancer Patients: A Review of Available Methods and an Overview on Future Perspectives
por: Fiz, Francesco, et al.
Publicado: (2018)

Castration-Resistant Prostate Cancer Tissue Acquisition From Bone Metastases for Molecular Analyses
por: Lorente, David, et al.
Publicado: (2016)

Bone metastases and skeletal-related events from neuroendocrine tumors
por: Van Loon, Katherine, et al.
Publicado: (2015)

Evaluation of Tumor Viability for Primary and Bone Metastases in Metastatic Castration-Resistant Prostate Cancer Using Whole-Body Magnetic Resonance Imaging
por: Iwamura, Hiromichi, et al.
Publicado: (2018)

Prostate-specific antigen for prediction of skeletal metastases on bone scintigraphy in prostate cancer
por: Hammond, Emmanuel Nii Boye, et al.
Publicado: (2021)

The effects of nonspecific HIF1α inhibitors on development of castrate resistance and metastases in prostate cancer
por: Ranasinghe, Weranja K B, et al.
Publicado: (2014)

A rare case of isolated castrate resistant bilateral testicular metastases in advanced prostate cancer
por: Su, Jiarui, et al.
Publicado: (2018)

Single-center experience with radium-223 in patients with castration-resistant prostate cancer and bone metastases
por: Kapoor, Anil, et al.
Publicado: (2019)

Bisphosphonates in oncology: evidence for the prevention of skeletal events in patients with bone metastases
por: Polascik, Thomas J
Publicado: (2009)

Health state utilities for skeletal-related events secondary to bone metastases
por: Matza, Louis S., et al.
Publicado: (2013)

Molecular Mechanisms of Bone Metastasis: Which Targets Came from the Bench to the Bedside?
por: Casimiro, Sandra, et al.
Publicado: (2016)

A single arm phase II study of bone-targeted Sn-117 m-DTPA in symptomatic castration-resistant prostate cancer with skeletal metastases
por: Myint, Zin W., et al.
Publicado: (2022)

Assessing the quality of life of patients with metastatic castration-resistant prostate cancer with bone metastases receiving [(223)Ra]RaCl(2) therapy
por: Sraieb, Miriam, et al.
Publicado: (2020)

Response to [(177)Lu]Lu-PSMA radioligand therapy in metastatic castration-resistant prostate cancer patients presenting with only lymph node metastases
por: Zisser, Lucia, et al.
Publicado: (2022)

Paradoxical response of prostate cancer skeletal metastases to androgen deprivation therapy
por: Wosnitzer, Brian, et al.
Publicado: (2015)

HER-2/neu diagnostics in breast cancer
por: Carney, Walter P, et al.
Publicado: (2007)

Skeletal and extraskeletal manifestations of mixed alpha and beta thalassemia
por: Cox, Susan, et al.
Publicado: (2015)

Partial response of liver metastases treated with abiraterone in castration-resistant prostate cancer: A case report
por: MARECH, ILARIA, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_22r4f54lmv1dda4fn36ufk16qo